Clinical Outcomes of Anti-programmed Death-1 Antibody–Related Pneumonitis in Patients with Non-Small Cell Lung Cancer
Takafumi Koyauchi, Naoki Inui, Masato Karayama, Yoshihiro Kitahara, Sho Takuma, Yusuke Amano, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Mitsuru Niwa, Nao Inami, Yasuhiro Ito, Hideki Kusagaya, Shun Matsuura, Yusuke Kaida, Tomohiro Uto, Dai Hashimoto, Takashi Matsui, Kazuhiro Asada, Hiroyuki Matsuda, Masato Fujii, Mikio Toyoshima, Takafumi Suda
Topics & Concepts
PneumonitisMedicinePembrolizumabNivolumabIncidence (geometry)Lung cancerPleural effusionInternal medicineHypersensitivity pneumonitisAdverse effectCancerGastroenterologyLungImmunotherapyPhysicsOpticsCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies